Capital Flow Monitor · Sponsors · CIK 1671502
Quoin Pharmaceuticals Ltd.
42127 PLEASANT FOREST COURT, ASHBURN, VA, 20148-7349 · (703) 980-4182
Pharmaceuticals · Corporation· inc. ISRAEL true
Fit score
—
Offering
$105.3M
Sold
$105.3M
% sold
100.0%
Investors
27
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-09-10 | D | 506(b) | $50.0M | $50.0M | 100.0% | 33 | EDGAR ↗ |
| 2025-10-23 | D ·current | 506(b) | $105.3M | $105.3M | 100.0% | 27 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Michael Myers — Executive Officer / Director, Ashburn, VA
- Sally Bridget Lawlor — Executive Officer, Ashburn, VA
- Denise Carter — Executive Officer / Director, Ashburn, VA
- Joseph Cooper — Director, Ashburn, VA
- James Culverwell — Director, Ashburn, VA
-
Dennis Langer — Director, Ashburn, VA
2 other raises
- NexEos Diagnostics, Inc. $3.0M of $3.0M · 100.0%
- Avicenna Biosciences, Inc. $71K of $71K · 100.0%
- Natalie Leong — Director, Ashburn, VA
- Michael Sember — Director, Ashburn, VA
Placement agents
- Maxim Group Llc · 0 RE raises
- Leerink Partners Llc · 0 RE raises
- Btig, Llc · 0 RE raises
- Lake Street Capital Markets Llc · 0 RE raises
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.